William J. Enright

2017

In 2017, William J. Enright earned a total compensation of $1M as Chief Executive Officer at PharmAthene, a 116% increase compared to previous year.

Compensation breakdown

Bonus$87,450
Option Awards$575,000
Salary$368,285
Other$14,399
Total$1,045,134

Enright received $575K in option awards, accounting for 55% of the total pay in 2017.

Enright also received $87.5K in bonus, $368.3K in salary and $14.4K in other compensation.

Rankings

In 2017, William J. Enright's compensation ranked 8,772nd out of 14,666 executives tracked by ExecPay. In other words, Enright earned more than 40.2% of executives.

ClassificationRankingPercentile
All
8,772
out of 14,666
40th
Division
Manufacturing
3,348
out of 5,772
42nd
Major group
Chemicals And Allied Products
1,133
out of 2,075
45th
Industry group
Drugs
902
out of 1,731
48th
Industry
Pharmaceutical Preparations
708
out of 1,333
47th
Source: SEC filing on July 26, 2018.

Enright's colleagues

We found three more compensation records of executives who worked with William J. Enright at PharmAthene in 2017.

2017

Sybil Tasker

PharmAthene

Chief Medical Officer

2017

Elizabeth Czerepak

PharmAthene

Chief Financial Officer

2017

John Gill

PharmAthene

Chief Executive Officer

News

In-depth

You may also like